Kymera Therapeutics, Inc.
2021 Q3 - 2025 Q4 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 985 | 0.0% | 12,655 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 693 | 0.0% | 12,245 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 534 | 0.0% | 12,245 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 335 | 0.0% | 12,245 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 493 | 0.0% | 12,245 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 580 | 0.0% | 12,245 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 366 | 0.0% | 12,245 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 375 | 0.0% | 12,645 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 278 | 0.0% | 10,925 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 152 | 0.0% | 10,925 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 248 | 0.0% | 10,785 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 375 | 0.0% | 12,645 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 316 | 0.0% | 12,645 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 406 | 0.0% | 18,665 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 368 | 0.0% | 18,665 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 378 | 0.0% | 8,935 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 567 | 0.0% | 8,935 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 480 | 0.0% | 8,171 | 9/30/2021 |